Adam Sun
感谢杨博士。欢迎大家参加我们的电话会议。首先,我想回顾一下我们2015年第二季度的财务业绩亮点。我们的总净收入同比增长8.5%,达到1.745亿元人民币(合2820万美元),而2014年第二季度为1.608亿元人民币。总收入由网络业务收入1.66亿元和收购的Fortis外科医院收入820万元组成。毛利润为7920万元(合1280万美元),而2014年第二季度为9360万元。归属于普通股股东的净利润同比增长4.4%,达到3650万元(合590万美元),而2014年第二季度为3500万元,其中包括Fortis外科医院780万元(合130万美元)的净亏损。我们的基本和稀释后每份ADS收益均为0.81元人民币(合0.13美元),而2014年第二季度为0.78元人民币。调整后EBITDA(非GAAP)为6600万元(合1060万美元),而2014年第二季度为9240万元。现在让我按业务板块谈谈我们2015年第二季度的财务业绩,首先是网络业务。在网络业务方面,我们在2015年第二季度关闭了三个放疗中心。截至2015年6月30日,我们在中国53个城市运营着129个中心网络,并已签订协议建立另外两个中心。网络业务的总净收入同比增长3.4%,达到1.663亿元(合2680万美元),而去年同期为1.608亿元。网络业务的收入成本为8180万元(合1310万美元),而去年第二季度为6720万元。我们非常高兴地看到PET-CT和Cyber Knife部门的收入贡献显著增长,占总收入的百分比也同比增长,这证明我们的产品组合改善策略取得了成效。本季度,我们的PET-CT收入同比增长31%,Cyber Knife收入同比增长72%。这两个部门在第二季度约占我们总收入的1/3。网络业务的毛利润为8480万元(合1370万美元),本季度网络业务的毛利率为51.0%,而2014年第二季度为58.2%。毛利润下降的主要原因是网络业务医疗耗材费用增加导致收入成本上升。我们预计网络业务的毛利率将在今年剩余时间稳定在当前水平。本季度,我们的网络发展符合预期,实现了成本线和底线稳定增长。我们将在现有中心的产品组合和效率改进方面做出更多努力,并在我们拥有现有资源和强大患者需求的地区,有选择地将现有中心转变为独立的自有中心。医院业务。Fortis外科医院是新加坡领先的私营营利性医院,拥有31张床位和80名医疗和非医疗人员。作为我们整体战略的重要组成部分,我们于今年3月收购了这家医院。目前公司正在将其转型为癌症专科医院。本季度医院业务的净收入为820万元(合130万美元),其中住院收入占总收入的88%,其余包括门诊收入5%和医疗收入7%。医院业务的医疗服务成本为1380万元(合220万美元)。医院业务的毛利率为负,因为我们正在将医院转型为癌症专科医院。完成后,该医院将为来自中国大陆的癌症患者提供MD安德森标准的肿瘤治疗服务,特别是高端癌症患者。医院的盈利能力将得到极大改善。我们预计转型将在今年第四季度完成。此外,在完成对德克萨斯大学和MD安德森癌症中心质子治疗中心额外所有权的收购后,康华医疗现已成为质子中心管理公司的控股股东,并将从今年第三季度开始合并其财务业绩。我们预计该业务将带来增量收入贡献。我们的准备发言到此结束。感谢大家的关注。现在,我们开始接受提问。
Adam Sun
Thank you, Dr. Yang. Welcome everyone to our call. First, I would like to review the highlights of our second quarter 2015 financial results. Our total net revenue increased by 8.5% to RMB174.5 million or $28.2 million in the second quarter of 2015 or RMB160.8 million in the second quarter of 2014. The total revenue is composed of revenue on the network business of RMB166 million and on the acquired Fortis Surgical Hospital of RMB8.2 million. Gross profit was RMB79.2 million or $12.8 million, compared to RMB93.6 million in the second quarter of 2014. Our net income attributable to ordinary shareholders increased by 4.4% to RMB36.5 million or RMB5.9 million or RMB35 million for the second quarter of 2014, which includes the net loss of Fortis Surgical Hospital of RMB7.8 million or $1.3 million. Our basic and diluted earnings per ADS for both RMB0.81 or $0.13 compared with RMB0.78 in the second quarter of 2014. Adjusted EBITDA non-GAAP was RMB66 million or $10.6 million compared to RMB92.4 million in the second quarter of 2014. Now let me talk about our financial results for the second quarter of 2015 by segment, network business. Network business. In the network business, we closed three radiotherapy centers in the second quarter of 2015. As of June 30, 2015, we operated a network of 129 centers in 53 cities in China and have entered into agreements to establish two additional centers. Total net revenue from the network business increased by 3.4% to RMB166.3 million or $26.8 million for RMB160.8 million in the second quarter last year. Cost of revenue for the network business was RMB81.8 million or $13.1 million compared to RMB67.2 million in the second quarter of last year. We are very pleased to see significant growth in the revenue contribution by both PET-CT and Cyber Knife sectors the percentage of the total revenue has also increased year-over-year as our product mix improvement strategy paid off. During the quarter, our PET-CT revenue increased 31% year-over-year and our Cyber Knife revenue increased 72% year-over-year. The two sectors accounted for about one third of our total revenue in the second quarter. Gross profit from the network business was RMB84.8 million or $13.7 million and the gross profit margin of the network business for the quarter was 51.0%, compared to 58.2% for the second quarter of 2014. The decrease in gross profit was mainly due to higher cost of revenue attributable to the increased medical consumable expenses for the network. We expect the gross margin of the network business to be stable at the current level for the rest of the year. In this quarter, our network developed in line with our expectations achieving both cost line and bottom line stable growths. We will make more efforts in the product mix and efficiency improvement to our existing centers and selectively transform the existing centers into freestanding self-owned centers in the areas which we have existing resources and strong patient demand. Hospital Business. Fortis Surgical Hospital is the leading private-owned for-profit hospital in Singapore which operates 31 beds and have 80 medical and non-medical staff. As an important part of our overall strategy, we acquired this hospital in March this year. Currently the Company is transforming it into a cancer specialty hospital. Net revenues from the hospital business were RMB8.2 million or $1.3 million for the quarter of which in-patient revenue accounted for 88% of the total revenue and the rest includes outpatient revenue of 5% and the medical revenue of 7%. Cost of service of the hospital business was RMB13.8 million or $2.2 million. Gross profit margin of the hospital business was negative due to the fact that we are in the process to transform the hospital into a speciality cancer hospital. When completed, the hospital will provide MD Anderson Standard Oncology treatment to cancer patients, the specialty high-end cancer patients from Mainland China. The profitability [ph] of the hospital will see tremendous improvement. We expect the transformation will be completed by the fourth quarter of this year. In addition, after closing the acquisition of additional ownership interest of the University of Texas and MD Anderson, Cancer Center Proton Therapy Center – Concord Medical is now the controlling shareholder of the management company of Proton Center and will consolidate its financial results beginning in the third quarter of this year. We expect to see incremental revenue contribution from the business. That concludes our prepared remarks. Thank you for your attention. Now, we would like to open up for questions.